Empower Clinics Inc. (CSE:CBDT, OTCQB:EPWCF) has announced the launch of its coronavirus (COVID-19) testing solutions for cruise travel passengers in Vancouver, British Columbia.
The launch follows the signing of a Memorandum of Understanding (MoU) for healthcare services, COVID-19 testing and logistics management with Ceres Terminals Canada, the operator of the cruise ship terminal at Canada Place, announced on February 10, 2022.
"As a proud Vancouver company, we are honoured to play a part in the safe return of the cruise ship industry to our city," Steven McAuley, chairman and CEO of Empower Clinics said in a statement.
"We have worked closely with Ceres for over 18 months. Our teams have worked tirelessly and with patience to understand the needs of cruise ship companies in these new times, together securing logistics, talent and technology to offer a high-quality and convenient solution to their passengers," he added.
READ: Empower Clinics closes non-brokered private placement of unsecured convertible debenture for aggregate gross proceeds of $2.1M
McAuley said the launch of the testing service builds on the company’s past bespoke COVID-19 solutions delivered to clients in the US and demonstrates Empower's ability to be responsive, agile and comprehensive in its service delivery.
The integrated healthcare company noted that Ceres handled almost 1.1 million passengers and 300 vessels at the cruise terminal during the 2019 cruise ship season.
Supported by an experienced leadership team, Empower Clinics is aggressively growing its clinical and digital presence across North America.
Contact the author at jon.hopkins@proactiveinvestors.com